| Document and Entity Information | Dec. 14, 2023 |
| Document And Entity Information [Line Items] | |
| Entity Registrant Name | PFIZER INC |
| Amendment Flag | true |
| Entity Central Index Key | 0000078003 |
| Document Type | 8-K/A |
| Document Period End Date | Dec. 14, 2023 |
| Entity Incorporation State Country Code | DE |
| Entity File Number | 1-3619 |
| Entity Tax Identification Number | 13-5315170 |
| Entity Address, Address Line One | 66 Hudson Boulevard East |
| Entity Address, Postal Zip Code | 10001-2192 |
| Entity Address, City or Town | New York |
| Entity Address, State or Province | NY |
| City Area Code | (212) |
| Local Phone Number | 733-2323 |
| Written Communications | false |
| Soliciting Material | false |
| Pre Commencement Tender Offer | false |
| Pre Commencement Issuer Tender Offer | false |
| Entity Emerging Growth Company | false |
| Amendment Description | On December 14, 2023, Pfizer Inc. filed a Current Report on Form 8-K with Items 2.01, 7.01 and 9.01 (the “Original Report”). Due to a clerical error, the submission header coding in the Original Report inadvertently referred to Item 2.02 on EDGAR and not to Item 2.01. This Amendment No. 1 on Form 8-K/A is being filed for the sole purpose of correcting the submission header coding to refer to Items 2.01, 7.01 and 9.01. All disclosures contained in the Original Report remain unchanged. |
| Common Stock [Member] | |
| Document And Entity Information [Line Items] | |
| Security 12b Title | Common Stock, $0.05 par value |
| Trading Symbol | PFE |
| Security Exchange Name | NYSE |
| Deferrable Notes [Member] | |
| Document And Entity Information [Line Items] | |
| Security 12b Title | 1.000% Notes due 2027 |
| Trading Symbol | PFE27 |
| Security Exchange Name | NYSE |
